background Subjects with normal body mass index but high body fat percentage have higher cardiovascular risk than subjects with normal weight and low fat mass. However, the association of fat distribution and lean mass with carotid-femoral pulse wave velocity (cfPWV) among nonobese apparently healthy individuals has never been assessed.
Body fatness, particularly central fatness, is a major risk factor for cardiovascular disease. 1, 2 In contrast, peripheral fat, particularly leg mass, seems to confer a protective effect. 3 Low skeletal muscle mass or sarcopenia is associated with increased cardiovascular risk. 4, 5 Although the definition of obesity is an excess in body fat, in clinical practice and epidemiologic studies, body mass index is generally used to define excess adiposity. Nevertheless, a significant limitation of using body mass index (BMI) is its failure to differentiate between an elevated body fat content and preserved or increased lean mass, especially in individuals with a BMI <30 kg/m 2 . Furthermore BMI does not assess fat distribution. 6, 7 Recent studies have shown that individuals with normal BMI but increased body fat mass have more metabolic dysregulation and higher mortality than subjects with normal BMI and low fat mass. 8 However, the potential mechanisms through which body adiposity might affect vascular health in people without obesity have not been elucidated.
A possible mechanism by which body composition affects cardiovascular disease is through increased arterial stiffness. 9 Increased arterial stiffness increases the workload on the heart and increases pressure and flow pulsatility in the brain and kidneys, leading to microvascular damage. 10, 11 The effect of aging and cardiovascular risk factors on the aorta is greater than on the peripheral arteries. 12, 13 This makes the aorta an ideal target for studies of the obesity influence on arterial stiffness.
Previous studies have estimated the influence of fat mass distribution on different arterial territories with discrepant results. [14] [15] [16] [17] [18] This may have been because arterial stiffness was evaluated in peripheral arteries, 3, 14 which have limited ability to predict cardiovascular risk, or because central arterial stiffness was estimated with techniques that were not validated to predict cardiovascular risk. 14 Furthermore, there is increasing evidence that sarcopenia is associated with increased arterial stiffness. [19] [20] [21] However, there is limited data on the association between lean mass content and aortic stiffness and the potential additive effect of body fat mass, central fat distribution, and decreased muscle mass on arterial stiffness. The potential mediators of such association have not been identified.
The aim of this study was to evaluate the effect of fat distribution and lean mass on aortic stiffness, both estimated using state-of-the-art techniques in nonobese individuals without manifest cardiovascular disease. We hypothesized that, among nonobese individuals, central fat distribution coupled with low lean mass is associated with higher carotid-femoral pulse wave velocity (cfPWV) as compared with noncentral fat distribution. Furthermore, we evaluated possible mediators of the association between fat mass distribution and lean mass on aortic stiffness.
METHODS

Population
In total, 141 apparently healthy, nonobese volunteers without cardiovascular risk factors and manifest cardiovascular disease were recruited through advertisements and word of mouth and also from the Cardiovascular Health Clinic and from outpatient clinics from the Divisions of Preventive, Community and General Internal Medicine at the Mayo Clinic. Inclusion criteria were aged 30-65 years and BMI of 18.5-29.9 kg/m 2 .
Exclusion criteria were pregnancy, breastfeeding, secondary causes of excessive adiposity, conditions that increase body weight without necessarily increasing body fat such as liver cirrhosis, nephrotic syndrome, and other conditions with increased third space volume that may affect the measurements of body composition. Furthermore, we excluded patients with a history of myocardial infarction, unstable angina requiring hospitalization, coronary revascularization, positive stress test, stroke, transitory ischemic attacks, peripheral vascular disease, history of carotid endarterectomy, aortic aneurysm, vasculitis, and current smokers or subjects with past history of heavy smoking. Current smoking was defined as smoking any amount of tobacco during the last 12 months, and significant past smoking was defined as a 20 pack-year history of smoking, regardless of the date the subject quit. Smokers and ex-smokers were excluded to avoid the negative confounding that smoking causes. To minimize reverse causality we also excluded patients with a history of type 1 diabetes mellitus and patients who have experienced voluntary or involuntary weight loss >10% within the last 2 years and those who had undergone bariatric surgery. Other exclusions were terminal or chronic waste-related conditions, such as end-stage renal and liver disease, advanced lung disease, and any cancer. Also subjects with a history of hypertension or type 2 diabetes mellitus were excluded. The institutional review boards of the Mayo Clinic approved this study.
Anthropometric measures
Patients were weighed 3 times, 1 minute apart, between 8 am and 10 am in the fasting state, without shoes and with only light clothing using standardized scales. Scales were checked every day for accuracy using a 20-kg standard and were adjusted accordingly. Height was determined using a wall-mounted stadiometer. All anthropometric measurements were done by a single study nurse dedicated to the project.
body composition
Regional (arm, legs, and trunk) body fat and body lean mass were measured with whole-body dual-energy X-ray absorptiometry (DEXA) using the GE Lunar Prodigy DEXA (GE Healthcare, Waukesha, WI). The body regions were delineated with the use of specific anatomical landmarks.
Aortic stiffness
cfPWV is a noninvasive and reproducible parameter considered the gold standard of aortic stiffness measurement. 22 It is an independent predictive factor for all-cause and cardiovascular morbidity and mortality in patients with various levels of cardiovascular risk. 9 In this study, cfPWV was measured using the SphygmoCor device (AtCor Medical, West Ryde, New South Wales, Australia) in the recumbent position following the expert consensus. 22 Electrocardiograph-gated consecutive registration of the pulse waves at the carotid and femoral arteries was done, and the time shift (Δt) between the wave feet was calculated. The traveled distance (D) was calculated by subtracting the distance from the jugular fossa to carotid pulsation from the distance from jugular fossa to the pulsation of the femoral artery in the groin. Pulse wave velocity was calculated as D (meters) / Δt (seconds). The betweenday coefficient of variability of cfPWV in our laboratory is 7%.
Measurement of potential mediators
Glucose level was measured photometrically from plasma using the Roche Hitachi 912 Chemistry Analyzer (Roche Diagnostics, Indianapolis, IN). Total cholesterol and triglyceride concentrations were measured by enzymatic procedures, and high-density lipoprotein cholesterol was measured by dextran-sulfate-magnesium precipitation. Plasma insulin levels were measured with a radioimmunoassay. The HOMA2-IR index was obtained by the program HOMA Calculator (http://www.dtu.ox.ac.uk). Plasma leptin levels were measured using an RIA kit (Linco, St. Louis, MO). Inter-and intra-assay coefficients of variation in our laboratory are 7.0% and 5.1%, respectively. Adiponectin was measured by human adiponectin RIA kit (Linco Research, St. Charles, MO). In our laboratory, the inter-and intra-assay variations in adiponectin levels are 13% and 5%, respectively.
Statistical analysis
Descriptive statistics are given as mean ± SD, median (interquartile range (IQR)), or frequency (percentage). Skewed data were log-transformed. The associations of body composition measures with cfPWV were assessed using Pearson's correlation and after adjustment for age and mean blood pressure (MBP). Because of the positive association between central fat distribution and lean mass (r = 0.49; P < 0.001) and hypothesized opposite association of cfPWV with central fat distribution and lean mass, separate covariables of fat distribution and lean mass could not fully cover the hypothesized complexity of the association. We created the variable (fat distribution × total lean mass) composed of a measurement of fat distribution and a measure of lean mass, combined. This variable is equivalent to the interaction term using these variables. Linear regression was used to model cfPWV. Age, heart rate, and MBP were forced into the model, together with height and weight to control for body size. Furthermore, a stepwise regression model was used; variables included in the models are listed under Table 3 . Standardized beta is reported as ß S . Differences between groups were compared using analysis of variance and analysis of covariance tests. Linear trend across groups was also tested. Furthermore, we examined possible mediators of the association between central fat distribution/lean mass and cfPWV. In cross-sectional studies, mediation analysis is considered a causal model that can suggest a direction of influence based on predefined causal associations. In brief, the predictor and the mediator are correlated, and the predictor and the outcome are also correlated, and there is an implied causal path that links the three variables. As part of the aforementioned conditions necessary for mediation, we first confirmed the association of each mediator with both the predictor and the outcome. We then used a mediation pathway approach 23 to calculate the percentage decrease of ß S estimate for the interaction term after separately adjusting for possible mediators. To confirm the role of these variables as potential mediators, we also applied structural equation modeling with bootstrapping using the macro developed by Preacher and Hayes. 24 This explicitly models measurement error, allowing us to test hypotheses using the latent constructs. This analysis was used to estimate the path coefficients in a mediator model and to generate bootstrap confidence intervals for total and specific indirect effect (Supplementary Figure S1) . To bootstrap the sampling distribution of the specific and total indirect effects, a sample of size n cases was taken with replacement from the original sample. This process was repeated 5,000 times. The distributions of these estimates served as empirical, nonparametric approximations of the sampling distributions of the indirect effects. In the text, point estimate and 95% confidence intervals (CIs) for the indirect (mediator-mediated) pathway are provided, which is the difference between the total and direct effect. Calculations were performed using SPSS 19 software (SPSS, Chicago, IL). A 2-sided P value <0.05 was considered to be statistically significant.
rESULTS
From the sample of 141 subjects, 136 had complete data on body composition and aortic stiffness. Clinical characteristics of the study sample are shown in Table 1 . With regard to sex differences, women had higher fat mass in the arms, legs, and total body, whereas men higher BMI, lean mass in the arms, legs, and trunk, and total lean mass. There was no difference in cfPWV between men and women (7.4 m/s, IQR = 6.5-8.2 vs. 6.9 m/s, IQR = 6.3-8.0; P = 0.21).
Correlation between age, adiposity, lean mass, and pulse wave velocity There was no association between age and any of the fat or lean mass compartments (Table 2) , whereas there was a positive association between age and parameter of central fat distribution: trunk/total fat ratio. In univariate analysis, cfPWV was positively associated with trunk fat, total fat, and fat distribution, whereas after adjustment for age and MBP, only trunk/total fat ratio was independently associated with cfPWV (Table 2 ). In the fully adjusted model (Table 3) , there was a significant interaction between fat distribution and lean mass. Log transformed values of carotid-femoral pulse wave velocity (cfPWV), lean mass, and trunk/total fat were used. cfPWV data were adjusted for age and mean arterial pressure. *P < 0.05; **P < 0.01. We created a variable (fat distribution × total lean mass) composed of a measurement of fat distribution and a measure of lean mass combined. This variable is also equal to the interaction term using these variables. Hierarchical regression was used in model 1 with age, sex, height, weight, and heart rate forced into the model. Stepwise regression was used in models 2 (same covariables as in model 1) and 3 (model 2 + adiponectin). A standardized beta (β S ) of 0.1 indicates that when the independent variable increases by 1 SD, the dependent variable increases by 0.1 SD.
Fat mass distribution, lean mass, and pulse wave velocity
To further explore the interaction between fat distribution and lean mass, we compared the association between cfPWV and different combination of fat and lean mass distributions. We created groups below and over trunk/total fat ratio (median = 0.53) and total lean mass/height median (median = 24.3 kg/m). These groups were sorted according to hypothesized association between fat distribution and lean mass with PWV. Group 1 had noncentral fat distribution and high lean mass; group 2 had noncentral fat distribution and low lean mass; group 3 had central fat distribution and high lean mass; and group 4 had central fat distribution and low lean mass. Descriptive statistics of these groups are in Table 4 . In the model adjusted for age, sex, and MBP, aortic stiffness increased from group 1 to group 4 (P for linear trend < 0.001). Subjects with central fat distribution and low lean mass had higher cfPWV as compared with noncentral fat/ low lean mass group or noncentral fat/high lean mass group (Figure 1 ). When sex-stratified analyses with sex-specific cutoff values were performed, in the fully adjusted model cfPWV increased from group 1 to group 4 both in women (P for linear trend < 0.01) and men (P for linear trend < 0.05).
Mediators of the relationship between fat mass distribution/lean mass and cfPWV
As shown in Table 5 , only total cholesterol, low-density lipoprotein (LDL) cholesterol, and adiponectin were associated both with cfPWV and with the interaction term between fat distribution and lean mass. When adiponectin was entered into the stepwise linear regression analysis (Table 3, model 3) , the interaction term (fat distribution × lean mass) was not independently associated with cfPWV. However when total or LDL cholesterol was included in separate stepwise regression analyses, they were not independently associated with cfPWV (data not shown). When the mediation pathway approach was used with adjustment for age and mean arterial pressure, the β estimate for the interaction term decreased by 84% when adjusted for adiponectin level, but decreased only by 20% and 9% when adjusted for LDL and total cholesterol, respectively. Similarly in the structural equation modeling, adiponectin was a significant mediator of the central fat-lean mass interaction with cfPWV (point estimate = 0.025; 95% CI = 0.001-0.056; P < 0.05), whereas neither total nor LDL cholesterol was an independent mediator. Adiponectin level was positively associated with leg fat mass and negatively associated with trunk fat mass. Data are expressed as mean ± SD, median [interquartile range], or frequency (%). Group 1 had noncentral fat distribution and high lean mass; group 2 had noncentral fat distribution and low lean mass; group 3 had central fat distribution and high lean mass; group 4 had central fat distribution and low lean mass.
Abbreviations: BMI, body mass index; cfPWV, carotid-femoral pulse wave velocity; CRP, C-reactive protein; DBP, diastolic blood pressure; HDL, high-density lipoprotein; HOMA, homeostasis model assessment; LDL, low-density lipoprotein; MAP, mean arterial pressure; NS, not significant; SBP, systolic blood pressure.
a Analysis of variance test. Non-normally distributed variables were log-transformed. b Weighted test for linear trends. Non-normally distributed variables were log-transformed. *P < 0.05 vs. group 1; **P < 0.05 vs. group 2; ***P < 0.05 vs. group 3.
DISCUSSIOn
This study in nonobese individuals without manifest cardiovascular disease demonstrates that (i) central fat distribution assessed as the ratio of trunk fat to total fat is more strongly associated with pulse wave velocity than total, trunk, or peripheral fat mass; (ii) central fat distribution combined with low lean mass is associated with higher aortic stiffness; and (iii) adiponectin is a mediator of the association between central fat distribution/lean mass and cfPWV.
Our finding that among nonobese individuals central fat distribution is associated with cfPWV beyond trunk or total fat mass is in line with previous studies from the general population 3, 17 in which peripheral fat mass was associated negatively whereas trunk fat was associated positively with arterial stiffness. However other studies found an association only between central arterial stiffness and visceral fat mass 16, 18, 21, 25 or no association with fat mass at all. 14 Our results suggest that fat distribution may be a stronger risk factor than absolute fat mass or fat mass percentage. This finding is in line with studies showing that fat distribution is a more important cardiovascular risk factor than the absolute degree of fatness per se 26, 27 and is consistent with the concept that adipose tissue accumulating preferentially in the trunk has an adverse effect on cardiovascular risk, whereas peripheral fat accumulation confers a protective effect. The opposite effect of central and peripheral fat mass may be explained by metabolic differences. Peripheral adipose tissue has higher lipoprotein lipase activity and low fatty acid turnover and shows an increased secretion of anti-inflammatory adipokines, whereas central fat has higher secretion of pro-inflammatory markers. 28 There is growing evidence that decreased skeletal muscle mass or sarcopenia is associated with increased cardiovascular risk independently of traditional risk factors. 4, 5, 29 Previously, negative association between peripheral lean mass 7, 30 or thigh muscle cross-sectional area/volume 20, 25 and central arterial stiffness was reported. We have extended these findings, showing that also lower whole body lean Table 5 . Univariate association of biochemical variables with carotid-femoral pulse wave velocity and the interaction term between trunk/total fat and trunk lean/height (total fat × lean mass) Only total cholesterol, low-density lipoprotein (LDL) cholesterol, and adiponectin are associated both with carotid-femoral pulse wave velocity (cfPWV) and with the interaction term between fat distribution and lean mass in univariate analysis.
Abbreviations: CRP, C-reactive protein; HDL, high-density lipoprotein; HOMA, homeostasis model assessment.
*P < 0.05; **P < 0.001. Figure 1 . The influence of fat distribution and lean mass on carotid-femoral pulse wave velocity (PWV). Trunk/total fat ratio (a measure of fat distribution) and total lean mass medians were used to categorize the study sample. Median and interquartile range are shown for unadjusted model (linear scale), whereas estimated marginal means and 95% confidence intervals are provided for general linear model adjusted for age, sex, and mean arterial pressure (logarithmic scale). Aortic stiffness increased with central fat distribution and total lean mass decrease.
mass is associated with higher cfPWV, particularly in subjects with central fat distribution. Normal weight obesity, which is defined by normal weight and increased body fat, is associated with a high prevalence of cardiometabolic dysregulation, metabolic syndrome, and risk of cardiovascular mortality. 8, 31 Our findings add significantly to the concept of normal weight obesity, showing that central fat distribution combined with low lean mass is more important than total fat content. Thus definition of normal weight obesity based on central fat distribution and decreased lean mass may improve identification of individuals with normal weight at increased cardiovascular risk. In the future, studies comparing standard definition of normal weight obesity with definition based on central fat distribution and lean mass content will be needed. Another important implication of our results is lifestyle intervention among individuals with normal weight obesity. Our results suggest that interventions (preferably through exercise) aimed at decreasing central fat content and increasing total lean mass may be effective in decreasing cardiovascular risk in this group.
In this study we have assessed possible mediators of the association between fat distribution/lean mass with cfPWV. Using 2 different statistical methods, we have shown that adiponectin may be the mediator of the association among nonobese, otherwise healthy individuals. In literature, the data on adiponectin association with PWV are inconsistent. [32] [33] [34] [35] [36] This may be because arterial stiffness was evaluated in different arterial territories or because the association between arterial stiffness and adiponectin level is modified by comorbidities such as diabetes and coronary heart disease. Compensatory increase of adiponectin in the increased inflammatory state was suggested. 30 The mechanism by which low adiponectin level influences arterial stiffness is not completely understood. However, adiponectin has been lately recognized as a dominant insulin-sensitive adipokine and, in contrast with other adipose-tissue derived cytokines, it has major antidiabetic, antiatherogenic, and anti-inflammatory properties. 37 Our study has to be interpreted within the context of its strengths and limitations. First, cross-sectional design of this study precludes us from drawing strong conclusions about causality, as this would require prospective design. Second, the DEXA measurement did not allow discrimination of trunk fat depots, particularly between subcutaneous vs. visceral. Visceral adipose tissue has been shown to be more closely associated with metabolic disturbances than subcutaneous adiposity. 38 However, others have also highlighted similar adverse effect of subcutaneous fat located in the trunk, as compared with subcutaneous fat in other depots. 2 Third, our results were obtained in nonobese individuals without cardiovascular risk factors and manifest cardiovascular disease; therefore inferences with regard to subjects with obesity and cardiovascular disease cannot be made from our results. Nonetheless, in patients with coronary heart disease, normal weight central obesity was found to be associated with the highest risk of mortality. 39 We did not control for the potential effect of menopausal status and the timing of the menstrual cycle on cfPWV in women. The strength of our study is a well-defined, apparently healthy, nonobese population without manifest cardiovascular disease, which allowed us to extend the concept of normal-weight obesity to an apparently healthy population. Furthermore, we used state-of-the-art techniques to evaluate aortic stiffness and body mass distribution, which makes our finding more relevant.
In conclusion, among normal weight, apparently healthy individuals without manifest cardiovascular disease, the combination of central fat distribution and low lean mass is independently associated with higher aortic stiffness, whereas total fat mass is not. These findings add significantly to the concept of normal weight obesity and might have important implications for healthy aging.
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